4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR
申请人:GlaxoSmithKline LLC
公开号:US20140171462A1
公开(公告)日:2014-06-19
Novel quinoline compounds pharmaceutical compositions containing such compounds and their use in therapy.